Orion Oyj (OTCMKTS:ORINY – Get Free Report) shares were up 2% on Wednesday . The company traded as high as $26.63 and last traded at $26.63. Approximately 155 shares changed hands during trading, a decline of 97% from the average daily volume of 5,747 shares. The stock had previously closed at $26.10.
Orion Oyj Price Performance
The company has a market cap of $7.52 billion, a PE ratio of 21.14 and a beta of 0.24. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.41 and a current ratio of 2.42. The stock has a 50 day moving average of $23.77 and a 200-day moving average of $24.61.
About Orion Oyj
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Further Reading
- Five stocks we like better than Orion Oyj
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Must-Have ETFs Set to Dominate This Quarter
- How to Effectively Use the MarketBeat Ratings Screener
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Trading Halts Explained
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Orion Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
